Integer Holdings Corporation (NYSE:ITGR) Receives $109.86 Consensus PT from Brokerages

Posted by Stanley Muller on Aug 22nd, 2026

Shares of Integer Holdings Corporation (NYSE:ITGR – Get Free Report) have received a consensus rating of “Hold” from the fourteen ratings firms that are presently covering the stock, MarketBeat.com reports. Thirteen research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $109.8571.

ITGR has been the subject of a number of analyst reports. KeyCorp cut shares of Integer from an “overweight” rating to a “sector weight” rating in a report on Monday, August 3rd. Oppenheimer cut Integer from an “outperform” rating to a “market perform” rating in a report on Monday, August 3rd. Raymond James Financial downgraded shares of Integer from a “moderate buy” rating to a “hold” rating in a research report on Monday, August 3rd. Wells Fargo & Company raised their price objective on shares of Integer from $84.00 to $127.00 and gave the stock an “equal weight” rating in a report on Tuesday, August 4th. Finally, Citigroup boosted their price objective on shares of Integer from $92.00 to $96.00 and gave the company a “neutral” rating in a research report on Wednesday, July 8th.

Check Out Our Latest Report on Integer

Integer Price Performance

ITGR opened at $125.22 on Wednesday. The stock has a market capitalization of $4.26 billion, a P/E ratio of 34.21, a price-to-earnings-growth ratio of 2.97 and a beta of 0.61. Integer has a one year low of $62.00 and a one year high of $126.14. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.73 and a quick ratio of 2.41. The company’s 50 day simple moving average is $104.12 and its 200-day simple moving average is $93.10.

Integer (NYSE:ITGR – Get Free Report) last issued its quarterly earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.38 by $0.22. Integer had a return on equity of 12.79% and a net margin of 6.97%.The business had revenue of $464.11 million for the quarter, compared to analyst estimates of $451.07 million. During the same quarter in the prior year, the firm posted $1.55 earnings per share. The firm’s revenue for the quarter was down 2.6% compared to the same quarter last year. Sell-side analysts anticipate that Integer will post 6.08 earnings per share for the current fiscal year.

Institutional Trading of Integer

A number of institutional investors have recently modified their holdings of ITGR. Salomon & Ludwin LLC boosted its position in shares of Integer by 46.8% during the fourth quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 118 shares during the period. Barrow Hanley Mewhinney & Strauss LLC bought a new stake in Integer in the 2nd quarter valued at approximately $29,000. EverSource Wealth Advisors LLC lifted its stake in Integer by 48.1% in the 1st quarter. EverSource Wealth Advisors LLC now owns 360 shares of the medical equipment provider’s stock valued at $32,000 after acquiring an additional 117 shares in the last quarter. TD Private Client Wealth LLC lifted its stake in Integer by 1,037.5% in the 4th quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock valued at $36,000 after acquiring an additional 415 shares in the last quarter. Finally, Parkside Financial Bank & Trust boosted its position in Integer by 135.5% during the 4th quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock worth $36,000 after acquiring an additional 267 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors.

Integer Company Profile

(Get Free Report)

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.